Cristcot, a clinical-stage pharmaceutical company advancing targeted therapies for gastrointestinal diseases, today announced that the Company will present its abstract evaluating the impact of ...
Biomerica, Inc. (Nasdaq: BMRA), a global biomedical technology company focused on innovative diagnostic-guided therapies, today announced that an abstract evaluating the real-world clinical ...
Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with ...
Poster Presentations featuring the latest advancements on anti-TROP2 (OBI 902) and Nectin-4 (OBI 904) ADCs, anti-TROP2/HER2 BsADC (OBI 201), anti-cMET/HER3Bs-Dual ...
The MarketWatch News Department was not involved in the creation of this content. Highlights the continued expansion of the diagnostic capabilities of the PanGIA Analysis System to include oral cancer ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acceptance of 31 abstracts—including one oral presentation—for the ...
THE WOODLANDS, TX, April 08, 2026 (GLOBE NEWSWIRE)-- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted ...
The poster will highlight the key components of the NEPHRO-CRRT study design, currently enrolling patients in the registrational study. There is an unmet medical need for safe, effective, and ...
HerResolve™ first and only assay validated against ground truth of laparoscopy with confirmed histology. Company to Exhibit at Booth #4 BOSTON, MA, UNITED STATES ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results